Cold and hot tumors: from molecular mechanisms to targeted therapy

B Wu, B Zhang, B Li, H Wu, M Jiang - Signal Transduction and Targeted …, 2024 - nature.com
Immunotherapy has made significant strides in cancer treatment, particularly through
immune checkpoint blockade (ICB), which has shown notable clinical benefits across …

[HTML][HTML] Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies

C Wang, S Dai, X Zhao, Y Zhang, L Gong, K Fu… - Biomedicine & …, 2023 - Elsevier
Celastrol is a pentacyclic triterpenoid extracted from the traditional Chinese medicine
Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular …

Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer

W Shao, Z Lin, Z **ahou, F Zhao, J Xu, X Liu… - Frontiers in …, 2024 - frontiersin.org
Background Ovarian carcinoma (OC) is a prevalent gynecological malignancy associated
with high recurrence rates and mortality, often diagnosed at advanced stages. Despite …

Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer

S Zhao, X Zhang, F Gao, H Chi, J Zhang… - Frontiers in …, 2023 - frontiersin.org
Background Ovarian cancer (OC) is one of the most common and most malignant
gynecological malignancies in gynecology. On the other hand, dysregulation of copper …

The application of Aptamer in biomarker discovery

Y Li, WW Tam, Y Yu, Z Zhuo, Z Xue, C Tsang, X Qiao… - Biomarker …, 2023 - Springer
Biomarkers are detectable molecules that can reflect specific physiological states of cells,
organs, and organisms and therefore be regarded as indicators for specific diseases. And …

Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis

D Ozmadenci, JS Shankara Narayanan… - Proceedings of the …, 2022 - pnas.org
High-grade serous ovarian cancer (HGSOC) is a lethal malignancy characterized by an
immunosuppressive tumor microenvironment containing few tumor infiltrating lymphocytes …

The complex tumor microenvironment in ovarian cancer: Therapeutic challenges and opportunities

B Garlisi, S Lauks, C Aitken, LM Ogilvie, C Lockington… - Current oncology, 2024 - mdpi.com
The tumor microenvironment (TME) in ovarian cancer (OC) has much greater complexity
than previously understood. In response to aggressive pro-angiogenic stimulus, blood …

CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer

G Acharya, C Mani, N Sah, K Saamarthy, R Young… - Cell Death …, 2024 - nature.com
Chemoresistance contributes to the majority of deaths in women with ovarian cancer (OC).
Altered DNA repair and metabolic signaling is implicated in mediating therapeutic …

Oncogenic pathways and targeted therapies in ovarian cancer

C Lliberos, G Richardson, A Papa - Biomolecules, 2024 - mdpi.com
Epithelial ovarian cancer (EOC) is one of the most aggressive forms of gynaecological
malignancies. Survival rates for women diagnosed with OC remain poor as most patients …

A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer

PZ Han, WD Ye, PC Yu, LC Tan, X Shi, XF Chen… - JCI …, 2024 - pmc.ncbi.nlm.nih.gov
Both anaplastic thyroid cancer (ATC) and papillary thyroid cancer (PTC) originate from
thyroid follicular epithelial cells, but ATC has a significantly worse prognosis and shows …